From Medscape Rheumatology

Medscape Medical News from the

European League Against Rheumatism (EULAR) Congress 2014

June 11 - 14, 2014; Paris, France

This coverage is not sanctioned by, nor a part of, the European League Against Rheumatism.

Conference News

EULAR Durable Drug-Free Remission Possible for RA
Medscape Medical News, June 23, 2014
EULAR First EULAR Imaging Recommendations for Spondyloarthritis
Medscape Medical News, June 20, 2014
EULAR Aerobic Exercise 'Most Effective Weapon' for Fibromyalgia
Medscape Medical News, June 19, 2014
EULAR Cost of Musculoskeletal Conditions Surprisingly High
Medscape Medical News, June 18, 2014
EULAR Attitudes Affect Adherence to Inflammatory Disease Meds
Medscape Medical News, June 18, 2014
EULAR Adalimumab Gets a Thumbs Up in Juvenile Idiopathic Arthritis
Medscape Medical News, June 16, 2014
EULAR Pregnancy Possible in Lupus Patients Taking Belimumab
Medscape Medical News, June 16, 2014
EULAR Gout Patients Should Be Screened for Erectile Dysfunction
Medscape Medical News, June 15, 2014

EULAR Stopping Immunotherapy Possible in Some Patients With Lupus
Medscape Medical News, June 15, 2014
EULAR Ultrasound Better Than Biopsy in Giant Cell Arteritis
Medscape Medical News, June 14, 2014
EULAR More Disease Activity in Obese Rheumatoid Arthritis Patients
Medscape Medical News, June 14, 2014
EULAR Increased Cardiovascular Risk in Sjögren's Syndrome
Medscape Medical News, June 14, 2014
EULAR Promising Results With Sarilumab in Rheumatoid Arthritis
Medscape Medical News, June 13, 2014
EULAR Biosimilars in Rheumatoid Arthritis: Wave of the Future?
Medscape Medical News, June 13, 2014
EULAR First Biomarkers for Severity of Osteoarthritis
Medscape Medical News, June 12, 2014
EULAR What's Hot at EULAR 2014
Medscape Medical News, June 9, 2014

Medscape Rheumatology© WebMD, LLC

Perspectives

Could This Rash Mean Malignancy?
Jonathan Kay, MD
Biologics or Not in RA? This Test Could Help Decide
Jonathan Kay, MD
A New Test for Juvenile Idiopathic Arthritis
Bret S. Stetka, MD; Sarah Ringold, MD
Are Docs Adhering to Targeted Treatment in RA?
Bret Stetka, MD; Iris J.M. Markusse, MD
Drugs for the Rarest Rheumatic Diseases
Jonathan Kay, MD
From Paris, New Data on Treating Rheumatoid Arthritis
Michael H. Schiff, MD
Biosimilars: As Good as the Originals?
Jonathan Kay, MD
Marijuana for Arthritis and Pain: Is There a Role?
Bret S. Stetka, MD

Poster Briefs

Psoriatic Arthritis and Cardiovascular Risk
Bret S. Stetka, MD; Agnete Malm G. Gulati, MD

Previous Coverage